Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05979337 · ClinicalTrials.gov registry record · NA
Brief Interventions in Chronic Migraine
A NA study of Chronic Migraine, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05979337: Active NA study of Chronic Migraine, sponsored by University of Michigan.
NCT05979337 is a NA study of Chronic Migraine that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 300 participants, roughly in line with the 326-participant average among 17 other Chronic Migraine trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05979337, a NA study of Chronic Migraine, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
People with chronic migraine headaches face many challenges, including high levels of daily pain, disturbances to everyday activities and sleep, and problems with mood such as depression or anxiety. This trial is being completed to study whether changing an individual's behaviors may have an impact as a treatment for migraine headaches. Eligible participants will be randomized to one of the four arms. This study will be conducted remotely without in-person contact. Study Hypothesis: * There is a main effect of attending either the Empowered Relief and Health Education intervention on reductions in migraine-related disability 1 month after completing either intervention * There is a main effect of Empowered Relief and Health Education interventions on reducing pain-related catastrophizing and migraine symptom severity 1 month after completing either intervention (secondary hypothesis) * The expected reductions in migraine-related disability, pain catastrophizing, and migraine symptom severity will be maintained at secondary time points (2 months, 3 months, and 6 months after completing either intervention) (secondary hypothesis)
Primary Outcome
The MIDAS is a 5-item questionnaire to measure the impact of headaches on life. Subjects indicate how many days headaches have impacted a specific activity. Score ranges: 0-5: little or no disability; 6-10: mild disability; 11-20: moderate disability: 21 (+) severe disability.
Conditions Studied
Interventions
- BEHAVIORAL Empowered Relief
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Health Education (HE)
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-10-11 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT05979337 still lists
NCT05979337 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 326-participant average among 17 other Chronic Migraine trials with a reported enrollment target.
The record links to 1 condition, with Chronic Migraine appearing as the primary indexed condition, and to 3 interventions - of which Empowered Relief is the first listed.
NCT05979337 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05979337 about?
NCT05979337 is a clinical study titled "Brief Interventions in Chronic Migraine". People with chronic migraine headaches face many challenges, including high levels of daily pain, disturbances to everyday activities and sleep, and problems with mood such as depression or anxiety. This trial is being completed to study whether changing an individual's behaviors may have an impact ...
What is the current status of trial NCT05979337?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-10-11. Estimated completion is 2027-01.
What conditions does trial NCT05979337 study?
This clinical trial studies the following conditions: Chronic Migraine.
What interventions are being tested in trial NCT05979337?
The interventions under investigation include: Empowered Relief (BEHAVIORAL), Treatment as Usual (BEHAVIORAL), Health Education (HE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05979337?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05979337 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05979337's enrollment target sits among peer trials
300 9th of 17 higher than 9 of 17 other Chronic Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
RECRUITING · NA
-
Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
-
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI